Catalyst Wire Dossier Catalyst Wire Dossier

Loteprednol etabonate ophthalmic ointment

loteprednol etabonate · Bausch & Lomb Incorporated
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Loteprednol etabonate ophthalmic ointment, covering 2010-09-23 to 2010-09-23. Get the full timeline:

Most recent: Clinical Trial Update: Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery [Phase 3]

See pricing